PRA Health (PRAH) Q4 Earnings Top Estimates, Revenues Up
Shares of PRA Health Sciences, Inc. PRAH rose 3.Array% to close at $43.97 on Feb 26, following the announcement of its fourth-quarter 20Array5 results. The contract research organization reported adjusted EPS (including stock-based compensation expense) of 57 cents in the fourth quarter of 20Array5, which managed to outpace the Zacks Consensus Estimate of 48 cents […]